Depression Clinical Trial
— MUSTPreventOfficial title:
Efficacy of Mindfulness-based Therapy vs. Relaxation in Prevention of Burnout in Medical Students : A Multicenter, Single Blind Randomized Controlled Study
A recent survey exploring mental health in a large cohort of French medical students and young graduates (N = 21.768), observed that 68.2% of participants showed pathologic anxiety. A high level of depressive symptomatology was found in 27.7% of participants, while suicidal ideation was reported by 23.7%. Mindfulness Based Interventions are beneficial for health with a positive impact on mood, anxiety, and well-being. It thus can be hypothesized that such interventions could help to prevent anxio-depressive symptomatology in medical students. The implementation of prevention programs to promote resilience to stress and empathy among medical students is a priority, included in French National Strategy for Health. Efficacy of Mindfulness Based Interventions in French university must be studied to confirm and strengthen their development. The originality of this project consists in the collaboration of medical schools from different cities and the longitudinal follow-up. The purpose of this study is to assess the efficacy of a mindfulness-based therapy in burnout prevention in comparison to relaxation.
Status | Recruiting |
Enrollment | 612 |
Est. completion date | September 4, 2024 |
Est. primary completion date | March 4, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Being enrolled in fourth or fifth year medical study - Having signed the informed consent - Being able to attend all scheduled visits and comply with all trial procedures Exclusion Criteria: - Suffering from a current depressive episode according to DSM-5 criteria - Suffering from a current panic disorder according to DSM-5 criteria - Pregnancy - Exclusion period in relation to another protocol - Not being affiliated to the French National Social Security System - Having reached 4500 € annual compensation for participation in clinical trials - Protection by law (guardianship or curatorship) - Deprivation of liberty (by judicial or administrative decision) - Planned longer stay outside the region that prevents compliance with the visit plan - For Paris students : participation in the optional teaching "Pleine conscience et médecine" (organized by Cloé Brami) - For Tours students : participation in the optional teaching on meditation organized by the faculty of medicine - For Strasbourg students : participation in the optional teaching on meditation (organized by Pr Bloch) |
Country | Name | City | State |
---|---|---|---|
France | CHU Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier | Centre Hospitalier Universitaire de Nimes, Hospices Civils de Lyon, INSERM U1061 Montpellier, University Hospital of Saint-Etienne, University Hospital, Angers, University Hospital, Clermont-Ferrand, University Hospital, Marseille, University Hospital, Paris, University Hospital, Strasbourg, University Hospital, Toulouse, University Hospital, Tours |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Emotional exhaustion assessed with the Maslach Burnout Inventory (MBI) | Evaluation of the emotional exhaustion based on the MBI score. The MBI contains three subscales, one of which assesses emotional exhaustion through 9 items. A score below 17 indicates a low degree of emotional exhaustion, a score between 18 and 29 indicates a moderate degree of emotional exhaustion and a score above 30 indicates a high degree of emotional exhaustion. Higher scores reflect greater experienced burnout. | at 12 months | |
Secondary | Emotional exhaustion assessed with the Maslach Burnout Inventory (MBI) | Description: Evaluation of the emotional exhaustion based on the MBI score. The MBI contains three subscales, one of which assesses emotional exhaustion through 9 items. A score below 17 indicates a low degree of emotional exhaustion, a score between 18 and 29 indicates a moderate degree of emotional exhaustion and a score above 30 indicates a high degree of emotional exhaustion. Higher scores reflect greater experienced burnout. | at 6 months | |
Secondary | Depersonalization assessed with the Maslach Burnout Inventory (MBI) | Evaluation of the emotional exhaustion based on the MBI score. The MBI contains three subscales, one of which assesses depersonalization through 5 items. A score below 5 indicates a low degree of depersonalization, a score between 6 and 11 indicates a moderate degree of depersonalization and a score above 12 indicates a high degree of depersonalization. Higher scores reflect greater experienced burnout. | at 6 months | |
Secondary | Depersonalization assessed with the Maslach Burnout Inventory (MBI) | Evaluation of the emotional exhaustion based on the MBI score. The MBI contains three subscales, one of which assesses depersonalization through 5 items. A score below 5 indicates a low degree of depersonalization, a score between 6 and 11 indicates a moderate degree of depersonalization and a score above 12 indicates a high degree of depersonalization. Higher scores reflect greater experienced burnout. | at 12 months | |
Secondary | Professional achievement assessed with the Maslach Burnout Inventory (MBI) | Evaluation of the emotional exhaustion based on the MBI score. The MBI contains three subscales, one of which assesses personal accomplishment through 8 items. A score below 33 indicates a low degree of personal accomplishment, a score between 34 and 39 indicates a moderate degree of personal accomplishment and a score above 40 indicates a high degree of personal accomplishment. Lower scores reflect greater experienced burnout. | at 6 months | |
Secondary | Professional achievement assessed with the Maslach Burnout Inventory (MBI) | Evaluation of the emotional exhaustion based on the MBI score. The MBI contains three subscales, one of which assesses personal accomplishment through 8 items. A score below 33 indicates a low degree of personal accomplishment, a score between 34 and 39 indicates a moderate degree of personal accomplishment and a score above 40 indicates a high degree of personal accomplishment. Lower scores reflect greater experienced burnout. | at 12 months | |
Secondary | Psychotropic and analgesic consumption | Collection of the name and dosage per month for each molecule | at 6 months | |
Secondary | Psychotropic and analgesic consumption | Collection of the name and dosage per month for each molecule | at 12 months | |
Secondary | Tobacco consumption | Number of cigarettes per day within the month | at 6 months | |
Secondary | Tobacco consumption | Number of cigarettes per day within the month | at 12 months | |
Secondary | Alcohol consumption | Frequency of the alcohol consumption within the month | at 6 months | |
Secondary | Alcohol consumption | Quantity of the alcohol consumption within the month | at 6 months | |
Secondary | Alcohol consumption | Frequency of the alcohol consumption within the month | at 12 months | |
Secondary | Alcohol consumption | Quantity of the alcohol consumption within the month | at 12 months | |
Secondary | Alcohol consumption assessed with the Alcohol Use Disorders Identification Test (AUDIT) | Quantity of alcohol consumed within the month as assessed with the AUDIT. Higher scores reflect high risk drinking | at 12 months | |
Secondary | Alcohol consumption assessed with the Alcohol Use Disorders Identification Test (AUDIT) | Frequency of alcohol consumed within the month as assessed with the AUDIT. Higher scores reflect high risk drinking | at 12 months | |
Secondary | Drug consumption | Collection of the name of consumed substances, frequency of the consumption within the month | at 6 months | |
Secondary | Drug consumption | Collection of the name of consumed substances, quantity of the consumption within the month | at 6 months | |
Secondary | Drug consumption | Collection of the name of consumed substances, frequency of the consumption within the month | at 12 months | |
Secondary | Drug consumption | Collection of the name of consumed substances, quantity of the consumption within the month | at 12 months | |
Secondary | Drug consumption assessed with the Drug Abuse Screening Test (DAST) | Drug consumption based on the DAST score. The total score ranges from 0 to 10. The higher the score the greater the problem related to drug consumption. | at 12 months | |
Secondary | Cannabis consumption | Frequency of the cannabis consumption within the month | at 6 months | |
Secondary | Cannabis consumption | Quantity of the cannabis consumption within the month | at 6 months | |
Secondary | Cannabis consumption | Frequency of the cannabis consumption within the month | at 12 months | |
Secondary | Cannabis consumption | Quantity of the cannabis consumption within the month | at 12 months | |
Secondary | Cannabis consumption assessed with the Cannabis Abuse Screening Test (CAST) | Cannabis consumption based on the CAST score. The total score ranges from 0 to 24. The higher the score the greater the problem related to cannabis consumption. | at 12 months | |
Secondary | Anxio-depressive symptomatology assessed with the Montgomery Asberg Depression Rating Scale (MADRS) | Anxio-depressive symptomatology based on the MADRS score. The total score ranges from 0 to 60. Scores between 0 and 6 indicates no depression, scores between 7 and 19 indicates mild depression, scores between 20 and 34 indicates moderate depression and scores above 34 reflects severe depression. | at 6 months | |
Secondary | Anxio-depressive symptomatology assessed with the Montgomery Asberg Depression Rating Scale (MADRS) | Anxio-depressive symptomatology based on the MADRS score. The total score ranges from 0 to 60. Scores between 0 and 6 indicates no depression, scores between 7 and 19 indicates mild depression, scores between 20 and 34 indicates moderate depression and scores above 34 reflects severe depression. | at 12 months | |
Secondary | Anxio-depressive symptomatology assessed with the Hospital Anxiety and Depression Scale (HADS) | Anxio-depressive symptomatology based on the HADS score. The questionnaire is divided in two subscales, one for anxiety and one for depression. Each subscore ranges from 0 to 21. Scores greater than or equal to 11 on either scale indicate anxious or depressive symptomatology. | at 6 months | |
Secondary | Anxio-depressive symptomatology assessed with the Hospital Anxiety and Depression Scale (HADS) | Anxio-depressive symptomatology based on the HADS score. The questionnaire is divided in two subscales, one for anxiety and one for depression. Each subscore ranges from 0 to 21. Scores greater than or equal to 11 on either scale indicate anxious or depressive symptomatology. | at 12 months | |
Secondary | Anxio-depressive symptomatology assessed with the Perceived Stress Scale (PSS) | Anxio-depressive symptomatology based on the PSS score. The total score ranges from 0 to 40. Higher scores reflect greater stress level. | at 6 months | |
Secondary | Anxio-depressive symptomatology assessed with the Perceived Stress Scale (PSS) | Anxio-depressive symptomatology based on the PSS score. The total score ranges from 0 to 40. Higher scores reflect greater stress level. | at 12 months | |
Secondary | Anxio-depressive symptomatology assessed with the Numerical Scale for psychological pain | Anxio-depressive symptomatology based on the Numerical Scale for psychological pain. The questionnaire is divided in three subscales, one for current psychological pain, one for usual psychological pain within the 15 last days and one for maximal psychological pain within the 15 last days. Each scale ranges from 0 to 10. Higher scores indicate greater psychological pain. | at 6 months | |
Secondary | Anxio-depressive symptomatology assessed with the Numerical Scale for psychological pain | Anxio-depressive symptomatology based on the Numerical Scale for psychological pain. The questionnaire is divided in three subscales, one for current psychological pain, one for usual psychological pain within the 15 last days and one for maximal psychological pain within the 15 last days. Each scale ranges from 0 to 10. Higher scores indicate greater psychological pain. | at 12 months | |
Secondary | Suicidality assessed with the Columbia Suicide Severity Rating Scale (C-SSRS) | Evaluation of suicidality through the C-SSRS. The suicidal ideation severity subscale ranges from 1 to 5 (with higher number indicating more severe ideation). The intensity of ideation subscale includes 5 questions each one ranging from 1 to 5 (with higher number indicating more intense ideation). The suicidal behavior subscale includes 4 yes/no questions. The suicidal behavior lethality subscale inquires about the level of actual or potential medical damage. | at 6 months | |
Secondary | Suicidality assessed with the Columbia Suicide Severity Rating Scale (C-SSRS) | Evaluation of suicidality through the C-SSRS. The suicidal ideation severity subscale ranges from 1 to 5 (with higher number indicating more severe ideation). The intensity of ideation subscale includes 5 questions each one ranging from 1 to 5 (with higher number indicating more intense ideation). The suicidal behavior subscale includes 4 yes/no questions. The suicidal behavior lethality subscale inquires about the level of actual or potential medical damage. | at 12 months | |
Secondary | Empathy assessed with the Jefferson Scale of Empathy for students | Evaluation of empathy based on the Jefferson Scale Empathy score. The total score ranges from 20 to 140. Higher scores reflect higher empathy. | at 6 months | |
Secondary | Empathy assessed with the Jefferson Scale of Empathy for students | Evaluation of empathy based on the Jefferson Scale Empathy score. The total score ranges from 20 to 140. Higher scores reflect higher empathy. | at 12 months | |
Secondary | Quality of life assessed with the World Health Organization Quality of Life (WHOQOL) | Quality of life based on the WHOQOL score. The total score ranges from 0 to 100. Higher scores reflect better health. | at 6 months | |
Secondary | Quality of life assessed with the World Health Organization Quality of Life (WHOQOL) | Quality of life based on the WHOQOL score. The total score ranges from 0 to 100. Higher scores reflect better health. | at 12 months | |
Secondary | Mindfulness assessed with the Five Facets Mindfulness Questionnaire (FFMQ) | Evaluation of mindfulness skills based on the FFMQ score. Higher scores indicate higher levels of mindfulness ability. | at 6 months | |
Secondary | Mindfulness assessed with the Five Facets Mindfulness Questionnaire (FFMQ) | Evaluation of mindfulness skills based on the FFMQ score. Higher scores indicate higher levels of mindfulness ability. | at 12 months | |
Secondary | Self- compassion assessed with the Self-Compassion Scale (SCS) | Evaluation of self-compassion skills based on the SCS score. The total score ranges from 26 to 130. Higher scores indicate higher levels of self-compassion. | at 6 months | |
Secondary | Self- compassion assessed with the Self-Compassion Scale (SCS) | Evaluation of self-compassion skills based on the SCS score. The total score ranges from 26 to 130. Higher scores indicate higher levels of self-compassion. | at 12 months | |
Secondary | Program adherence | Program adherence assessed with the number of attended sessions and the rates of dropout. | at 12 months | |
Secondary | Program acceptability | Program acceptability assessed with frequency of formal & informal practice of mindfulness, numerical rating scale for satisfaction and time spent doing exercises per week. | at 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |